Avid Bioservices Inc (CDMO)

[cjgaddy]

SITC’15 (Nov4-8): Peregrine Exhibiting; Abstracts Embargo'd till 11-3-15

Nov4-8 2015: “(SITC) Society for Immunotherapy of Cancer 30th Annual Meeting”, Natl-Harbor MD
”The premier destination for scientific exchange, education, and networking in the Cancer Immunotherapy Field”
SITC = The Society for Immunotherapy of Cancer http://www.sitcancer.org
SITC 2015 Meeting: http://www.sitcancer.org/2015
Abstract Embargo Lifted: 11-3-15 8am-Noon
Abstracts Published in Journal for ImmunoTherapy of Cancer: 11-4-15
EXHIBITOR: Peregrine Pharm. - booth #119 (directly across from #120/ASCO; AstraZeneca=#108)
...Floorplan: http://www.eventscribe.com/2015/sitc/exhibitors/index.asp
- - - -
SITC 2014: 3 Peregrine posters on preclin. Bavi+aCTLA4/aPD1 combo data (Hutchins Freimark Brekken Huang etal), and 1 poster by UTSW's Dr. Adam Yopp on the Bavi+Sorafenib/LIVER Ph2 IST: http://tinyurl.com/pchzr6h
.
.
= = = = = = = = = = = = = = = = = = = = = = = =
Rutgers' Dr. Raymond Birge, 10-29-15 John-Hopkins/Seminar: “PS is a Global-Immune-Checkpoint In Cancer”

Oct29 2015: “John Hopkins MMI/ID Research Seminar”, Baltimore
MMI = Molecular Microbiology & Immunology
12-1:00pm: "Phosphatidylserine is a Global Immune Checkpoint In Cancer"
Raymond Birge, PhD, Vice Chair, Professor, Dept of Molecular, Biochemistry & Molecular Genetics, Rutgers Univ., Biomedical & Health Sciences, Newark, NJ
Loc: Bloomberg School of Public Health W1020
Contact: Maryann Smith (John Hopkins Univ. http://www.jhu.edu )
https://calendar.jhu.edu/EventList.aspx?fromdate=10/24/2015&todate=10/30/2015&display=Week&type=public&eventidn=60196&view=EventDetails&information_id=136317
- - - - - - -
R.Birge Lab/Rutgers: http://birgelab.org
R.Birge Rutgers Profile: http://njms.rutgers.edu/resource_locator/find_people/profile.cfm?mbmid=birgera